HOXA5 and non-small cell lung carcinoma: Moreover, the combined data revealed that HOXA5 expression was correlated with prolonged survival in NSCLC (HR = 0.69, 95% CI = 0.57–0.84, P < .001), with nonsignificant heterogeneity (I2 = 31.9%, P = .209) (Table 3 and Fig. 3).